Primary Ovarian Insufficiency Clinical Trial
— IVADFPOIOfficial title:
Ovarian Tissue Cryopreservation and Auto-transplantation for in Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency
NCT number | NCT02322060 |
Other study ID # | RMCZZU-IVA |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 2014 |
Est. completion date | October 2021 |
In this study, the investigators used the newly developed technique i.e. in vitro activation
of dormant follicles (IVA) to promote ovarian follicle growth much more efficiently than
natural, in vivo process for women with Primary Ovarian Insufficiency (POI).Firstly, the
investigators remove one ovary under laparoscopic surgery. Then, we dissect ovarian cortex
from the ovarian medulla. The ovarian cortex is cut into small cubes and cultured with medium
containing drugs to activate dormant follicles. After 2 days of culture, the ovarian cubes
are transplanted mainly beneath the membrane of Fallopian tubes under laparoscopic surgery.
The ovarian cortex could be cryopreserve for future re-transplantation and in some cases, for
convenience to arrange second surgery. Once frozen, the ovary can be preserved
semipermanently. After transplantation, patients receive ultrasound monitoring together with
measurement of serum hormone levels for 10-12 months. If growing follicles are detected,
follicle growth is stimulated by injection of hormones (gonadotropins). Using the same "ovum
pick up" approach used in IVF (in vitro fertilization), we pick up oocytes from the follicles
and fertilize them. Fertilized eggs are cultured and then cryopreserved for future embryo
transfer.
Currently, we recurit patients diagnosed with POI, or Ovarian resistance syndrome (ORS). The
procedure can also be: Only superficial cut of the ovarian cortex by laparoscopy or
laparotomy, without taking ovary outside or cultured with medium.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | October 2021 |
Est. primary completion date | October 1, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 39 Years |
Eligibility |
Inclusion Criteria: - Married women (18-39) diagnosed with POI/ORS - With both ovaries present - With normal uterine cavity - Healthy and can stand surgery Exclusion Criteria: - Any one that does not meet the inclusion criteria |
Country | Name | City | State |
---|---|---|---|
China | Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University | Zhengzhou | Henan |
Lead Sponsor | Collaborator |
---|---|
The First Affiliated Hospital of Zhengzhou University | St. Marianna University School of Medicine, Stanford University |
China,
Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans MM. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update. 2006 Sep-Oct;12(5):519-35. Epub 2006 Jul 18. Review. — View Citation
Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, Ho CH, Kawamura N, Tamura M, Hashimoto S, Sugishita Y, Morimoto Y, Hosoi Y, Yoshioka N, Ishizuka B, Hsueh AJ. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17474-9. doi: 10.1073/pnas.1312830110. Epub 2013 Sep 30. — View Citation
Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK, Hsueh AJ. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10280-4. doi: 10.1073/pnas.1001198107. Epub 2010 May 17. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical pregnancy | Clinical pregnancy was confirmed by detection of one or more gestational sacs during transvaginal scan 4 weeks after embryo transfer. | 1 year | |
Secondary | Follicle growth | Detection of estrogen level elevation and follicle diameter increases reflecting follicle growth. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02871986 -
Pubertal Induction in Individuals With Hypogonadism
|
N/A | |
Recruiting |
NCT06167135 -
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
|
||
Active, not recruiting |
NCT04675970 -
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
|
||
Completed |
NCT04943354 -
Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure
|
N/A | |
Recruiting |
NCT03518918 -
Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women
|
||
Recruiting |
NCT05021094 -
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
|
Phase 4 | |
Active, not recruiting |
NCT02795000 -
Development a Predictive Nomogram for Primary Ovarian Insufficiency
|
||
Suspended |
NCT03021915 -
Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure
|
N/A | |
Completed |
NCT01436513 -
A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.
|
Phase 1 | |
Recruiting |
NCT06117982 -
The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency
|
Phase 2 | |
Recruiting |
NCT02068976 -
Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
|
||
Completed |
NCT01973075 -
Genetic Etiology in Premature Ovarian Insufficiency
|
N/A | |
Completed |
NCT03568708 -
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
|
Phase 3 | |
Not yet recruiting |
NCT02757469 -
Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
|
N/A | |
Completed |
NCT02091128 -
Pregnancy Chances in Classic Galactosemia
|
N/A | |
Terminated |
NCT00650754 -
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility
|
Phase 2/Phase 3 | |
Recruiting |
NCT03496636 -
Autologous Ovarian Tissue Transplantation
|
N/A | |
Active, not recruiting |
NCT05737329 -
Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02922348 -
Hormone Replacement for Premature Ovarian Insufficiency
|
Phase 3 | |
Completed |
NCT05310617 -
Parental Project and Premature Ovarian Insufficiency
|